Featured Stock Overview: Ocera Therapeutics, Inc. (OCRX)


Ocera Therapeutics, Inc. (OCRX) belonging to the Medical sector has surged 3.33% and closed its last trading session at $1.55.

The company reported its EPS on 03/09/2017. Currently, the stock has a 1 Year Price Target of $4.75.

The consensus recommendation, according to Zacks Investment research, is 1.67. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.

The Stock had a 1.5 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1 and 1 respectively.

Ocera Therapeutics, Inc. on 03/09/2017 reported its EPS as $-0.22 with the analysts projecting the EPS of the stock as $-0.34. The company beat the analyst EPS Estimate with the difference of $0.12. This shows a surprise factor of 35.3%.

Many analysts have provided their estimated foresights on Ocera Therapeutics, Inc. Earnings, with 3 analysts believing the company would generate an Average Estimate of $-0.23.

Whereas they predicted High and Low Earnings Estimate as $-0.22 and $-0.25 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.36.

Analysts are also projecting an Average Revenue Estimate for Ocera Therapeutics, Inc. as $20 Million in the Current Quarter. This estimate is provided by 2 analysts.

For the Current Quarter, the growth estimate for Ocera Therapeutics, Inc. is 36.1%, while for the Next Quarter the stock growth estimate is 30.3%.

The Company got Downgrade by JMP Securities on 31-Jan-17 from Mkt Outperform to Mkt Perform.

Insider Trades for Ocera Therapeutics, Inc. show that the latest trade was made on 6 Dec 2016 where Grais (Linda S), the Chief Executive Officer completed a transaction type “Buy” in which 7000 shares were traded at a price of $2.14.

Over the period of 6 months, Insider Purchases show a total of 5 transaction in which 50050 shares were traded.

4 analysts projected Price Targets for Ocera Therapeutics, Inc.. The analysts believe that the company stock price could grow as high as $11. The Low Price target projection by analysts is $1 and the Mean Price Target is $4.75.

Ocera Therapeutics, Inc. (OCRX) has the market capitalization of $48.38 Million. The company rocked its 52-Week High of $3.33 on Mar 21, 2016 and touched its 52-Week Low of $0.52 on Feb 7, 2017.

The stock has Return on Assets (ROA) of 0 percent. Return on Equity (ROE) stands at 0% and Return on Investment (ROI) of 0 percent.

The stock is currently showing YTD performance of -26.19 Percent. The company has Beta Value of 1.98 and ATR value of 0.18. The Weekly and Monthly Volatility stands at 13.98% and 13.58%.